*Some Market data delayed by 15 mins.

ICU Medical Inc

Symbol: ICUI (NASDAQ)
121.15 ▲ (0.99%) 1.190

Company Description:
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Key Stats
  • Today's Open: $119.67
  • Today's High: $123.825
  • Today's Low: $116.84
  • Today's Volume: 253.33K
  • Yesterday Close: $119.96
  • Yesterday High: $120.26
  • Yesterday Low: $115.8
  • Yesterday Volume: 203.14K
  • Last Min Volume: 5
  • Last Min High: $121.15
  • Last Min Low: $121.15
  • Last Min VWAP: $121.15
Company Profile
  • Name: ICU Medical Inc
  • Website: https://www.icumed.com
  • Listed Date: 1992-03-31
  • Location: SAN CLEMENTE, CA
  • Market Status: Active
  • CIK Number: 0000883984
  • SIC Code: 3841
  • SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • Market Cap: $2.96B
  • Round Lot: 100
  • Outstanding Shares: 24.69M
  • Asset Type: CS
RECENT FILINGS FOR ICUI
Filing Date Filing Type Format
2025-09-15 4 View
2025-08-27 4 View
2025-08-14 4 View
2025-08-14 SCHEDULE 13G/A View
2025-08-08 S-8 View
2025-08-07 10-Q View
2025-08-07 8-K View
2025-05-30 SD View
2025-05-30 144 View
2025-05-30 4 View
2025-05-28 4 View
2025-05-23 4 View
2025-05-21 4 View
2025-05-20 4 View
2025-05-19 4 View
2025-05-19 144 View
2025-05-15 4 View
2025-05-15 4 View
2025-05-15 144 View
2025-05-14 144 View

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.